DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
Adoptive T cell therapy using an allogeneic T cell graft is an encouraging therapeutic approach in cancer, but issues such as graft-versus-host disease can hinder applicability. Here, the authors show that DOT1L inhibition or DUSP6 overexpression in T cells attenuates graft-versus-host disease but r...
Enregistré dans:
Auteurs principaux: | Yuki Kagoya, Munehide Nakatsugawa, Kayoko Saso, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Marcus O. Butler, Cheryl H. Arrowsmith, Naoto Hirano |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d6ce55cb15b249f6b173e89e668c2976 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway
par: Yuki Yamashita, et autres
Publié: (2017) -
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
par: Yan-Ruide Li, et autres
Publié: (2021) -
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
par: Christopher Sloas, et autres
Publié: (2021) -
Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.
par: Peter D Kraus, et autres
Publié: (2012) -
Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
par: Uroosa Ibrahim, et autres
Publié: (2021)